KENILWORTH, N.J., February 17, 2022 /3BL Media/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, provided additional details today of the company’s virtual Investor Event in which its senior management team will discuss Environmental, Social & Governance (ESG) priorities. The event, scheduled for Wednesday, February 23 at 10:00 a.m. EST, will discuss the company’s long-term ESG strategies. These strategies focus on the company’s four ESG priority areas: Access to Health, Employees, Environmental Sustainability and Ethics & Value.

Investors, analysts, members of the media and the general public are invited to listen to the webcast of the presentation atMerck＆Co.，Inc。ESG活动-Merck.com. There will be a Q&A panel session with the senior management team following the prepared remarks. To submit a question in advance of the webcast, please send toinvestor_relations@merck.com.

关于Merck

For over 130 years, Merck, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visitwww.merck.com和connect with us on推特,Facebook,Instagram,YouTube和LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

风险和不确定性包括但不限于一般行业条件和竞争；一般经济因素，包括利率和货币汇率波动；全球新冠状病毒疾病爆发的影响（Covid-19）；美国和国际上制药行业监管和医疗立法的影响；全球医疗保健成本遏制的趋势；竞争对手获得的技术进步，新产品和专利；新产品开发固有的挑战，包括获得监管批准；该公司准确预测未来市场状况的能力；制造困难或延迟；国际经济和主权风险的财务不稳定； dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Learn more about the company’s commitment to diversity and inclusion in their Corporate Responsibility Report.

媒体：
约翰娜·赫尔曼（617）216-6029

Investors:
Peter Dannenbaum (908) 740-1037
Steven Graziano (908) 740-6582

Source: Merck & Co., Inc.